Spero Therapeutics, Inc. (NASDAQ:SPRO) Long Term Shareholder Notice: Investigation over Possible Wrongdoing Announced

An investigation on behalf of current long term investors in Spero Therapeutics, Inc. (NASDAQ:SPRO) shares over possible breaches of fiduciary duty by certain officers and directors was announced.


San Diego, CA -- (SBWire) -- 09/26/2022 --An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Spero Therapeutics, Inc.

Investors who are current long term investors in Spero Therapeutics, Inc. (NASDAQ: SPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: SPRO stocks follows a lawsuit filed against Spero Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: SPRO stocks, concerns whether certain Spero Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that the data submitted in support of the Tebipenem HBr NDA were insufficient to obtain FDA approval, that accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form, that the foregoing would necessitate a significant workforce reduction and restructuring of Spero's operations, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Spero Therapeutics, Inc. (NASDAQ: SPRO) have certain options and should contact the Shareholders Foundation.

Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Media Relations Contact

Michael Daniels
Shareholders Foundation, Inc.

View this press release online at: http://rwire.com/1364139